Clinical Trial Update: Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pegfilgrastim (Neulasta) for stem cell mobilization in patients with multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• NEULASTA (pegfilgrastim)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED